Allogene Therapeutics Announces Publication of Preclinical Study Results in Molecular Therapy Highlighting Potential for ALLO-715 (...
Anti-BCMA AlloCAR T Cells Maintained Phenotype and Sustained Potent Anti-Tumor Responses After Scaled-Up Manufacturing ALLO-715 Investigational New Drug Application and Phase 1 Trial Initiation Expected in 2019 SOUTH SAN FRANCISCO, Calif., April 15, 2019 ( …